Atherectomy Devises Market Segmented By Rotational Atherectomy Devices, Directional / excisional Atherectomy Devices, Orbital Atherectomy Devices, Laser Ablation Atherectomy Devices Device Type with Coronary Artery Diseases, Peripheral Artery Diseases Indication
Industry: Healthcare
Published Date: May-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 219
Report ID: PMRREP3516
The Atherectomy Devices Market witnessed a CAGR of 10% between 2014 and 2021. The global Atherectomy Devices Market is expected to have 11.8% CAGR between 2022 and 2026. In 2022, the global Atherectomy Devices Market size is US$ 991.1 million, which is projected to reach US$ 1,546.1 million by the year 2026.
Attribute | Key Insights |
---|---|
Atherectomy Devices Market Size (2022) |
US$ 991.1 Mn |
Projected Market Value (2026) |
US$ 1,546.1 Mn |
Global Market Growth Rate (2022-2026) |
11.8% CAGR |
Share in parent market |
56.7% |
The Atherectomy Devices Market is expected to grow at a CAGR of 11.8% during the forecast period between 2022 and 2026. The increased demand for minimally invasive treatments as well as the growing pool of patients is expected to drive the growth of the worldwide atherectomy devices market. The increased emphasis on technical improvements and the launch of new products is also expected to fuel market growth in the near future.
The rising prevalence of orthopedic disorders such as bone tumors and osteomyelitis is boosting the market growth. Atherectomy Devices are most commonly used to treat chronic osteomyelitis. Going forward, the increase in sports injuries and the other forms of trauma, bone lesions, and bone fractures are expected to fuel the market growth.
Growing incidences of peripheral artery diseases (PAD) and Coronary Artery Diseases (CAD) are expected to accelerate the Atherectomy Devices market. Research states that CADs and PADs affect 2 million Americans every year. Smoking, diabetes, and hypertension are the other factors leading to the rising occurrences of PADs and CADs. Atherectomy Devices are important in the treatment and management of peripheral artery disease (PAD). The devices provide several advantages, including a reduced possibility of complications and a better level of comfort throughout surgeries as compared to conventional treatments.
The rapidly expanding adoption of Laser Atherectomy Devices is likely to drive market expansion. As compared to mechanical systems, these devices provide several benefits like adaptability, enhanced efficiency, and the elimination of the need for embolic protection devices. Furthermore, laser-embedded atherectomy devices are capable of removing thrombi, dissolving procoagulant reactants, and debulking the underlying plaque without damaging the surrounding tissue. The modern laser atherectomy devices also provide exceptional precision along with a shorter recovery period and hospital stay. Hence, the increase in the adoption of laser atherectomy devices is expected to boost the market in the near future.
The increasing focus on technological advancements is estimated to bolster the market in the years to come. Furthermore, extensive research backing rapid expansion of medical infrastructure is expected to drive market growth during the forecast period.
People in developing countries have a limited understanding of the easy availability of disease diagnostics and therapies, which is expected to impede market expansion in the approaching years. Furthermore, scarcity of skilled surgeons is expected to limit market growth in the near future. However, relentless efforts made by the governments coupled investments are expected to promote the growth of the market in the upcoming period. Furthermore, the leading companies are focusing on emerging economies, which have the potential to evolve as mentioned above.
“Significant Decrease in Demand”
The COVID-19 pandemic wreaked havoc on the global economy, and it had a negative impact on the Atherectomy Devices Market between March 2020 and September 2021. The advent of COVID-19 led to a decrease in demand for Atherectomy Devices because the hospitals were flooded with Covid-19 patients. The unexpected outbreak of SARS-CoV-2 resulted in lockdown around the world, which caused a shutdown in significant areas of the global economy and caused supply chain disruptions, limiting commerce and transit of commodities and affecting industrial growth. The COVID-19 pandemic harmed the market by causing financial difficulties for enterprises as well as affecting output and demand, but the market has bounced back after September 2021
The Atherectomy Devices industry is moderately competitive and highly consolidated due to the presence of several large players. Key players in the market are focusing on mergers and acquisitions as the industry is in the growth phase. Companies are making strategic decisions regarding organic as well as inorganic expansion in order to expand their product portfolios and grow their market share.
Attribute | Details |
---|---|
Forecast Period |
2022-2026 |
Historical Data Available for |
2013-2021 |
Market Analysis |
US$ Mn/Bn for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
By Indication |
Key Companies Profiled |
|
Customization & Pricing |
Available upon Request |
Atherectomy Devices Market by Indication
Atherectomy DevicesMarket by Region
To know more about delivery timeline for this report Contact Sales
In 2022, the Atherectomy Devices Marketstands at USD 919.1 million, and it is expected to reach USD 1,546.1 million by 2026 at a CAGR of 11.8%.
Atherectomy Devices Market exhibited a 10% CAGR between 2013 and 2021.
Lack of awareness among people in the developing countries is the key restraint in the Atherectomy Devices Market.
The increasing Prevalence of Peripheral Arterial Diseases and Coronary Artery Diseases along with the Increase in the Adoption of Laser Atherectomy Devices are the key factors driving the growth of the market.
Medtronic Plc., Boston Scientific Corporation, Cardiovascular Systems, Inc., Avinger, Inc., and Koninklijke Philips N.V. (Spectranetics + Volcano) are among the top players in the market.